Literature DB >> 17656604

A novel mutation in the accessory DNA-binding domain of human steroidogenic factor 1 causes XY gonadal dysgenesis without adrenal insufficiency.

Anne L Reuter1, Katsumi Goji, Nathan C Bingham, Masafumi Matsuo, Keith L Parker.   

Abstract

OBJECTIVE: Steroidogenic factor 1 (SF1), officially designated NR5A1, is a nuclear receptor that plays key roles in endocrine development and function. Previous reports of human SF1 mutations revealed a spectrum of phenotypes affecting adrenal function and/or gonadal development and sex differentiation. We present the clinical phenotype and functional effects of a novel SF1 mutation. PATIENT: The patient is a 22-year-old 46, XY Japanese patient who presented with dysgenetic testes, atrophic vasa deferentia and epididymides, lack of Müllerian structures, and clitoromegaly. Endocrine studies revealed normal adrenal function.
RESULTS: Analysis of the SF1 gene revealed compound heterozygosity for a previously described p.G146A polymorphism and a novel missense mutation (p.R84C) in the accessory DNA-binding domain. The father carried the p.G146A polymorphism and the mother had the p.R84C mutation; both were clinically and reproductively normal. Functional studies demonstrated that the p.R84C SF1 had normal nuclear localization but decreased DNA-binding affinity and transcriptional activity compared with wild-type SF1; it did not exhibit any dominant negative activity.
CONCLUSIONS: These results describe the human phenotype that results from compound heterozygosity of the p.G146A polymorphism and a novel p.R84C mutation of SF1, thereby extending the spectrum of human SF1 mutations that impair testis development and sex differentiation in a sex-limited manner while preserving normal adrenal function.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17656604     DOI: 10.1530/EJE-07-0113

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  14 in total

Review 1.  Development and function of the human fetal adrenal cortex: a key component in the feto-placental unit.

Authors:  Hitoshi Ishimoto; Robert B Jaffe
Journal:  Endocr Rev       Date:  2010-11-04       Impact factor: 19.871

2.  Swyer's Syndrome: In a Fifty-Year-Old Female.

Authors:  Cavit Culha; Mesut Ozkaya; Rustu Serter; Ibrahim Sahin; Bayram Aydin; Yalcin Aral
Journal:  J Obstet Gynaecol India       Date:  2012-01-17

3.  Two regions within the proximal steroidogenic factor 1 promoter drive somatic cell-specific activity in developing gonads of the female mouse.

Authors:  Liying Gao; Youngha Kim; Bongki Kim; Stacey M Lofgren; Jennifer R Schultz-Norton; Ann M Nardulli; Leslie L Heckert; Joan S Jorgensen
Journal:  Biol Reprod       Date:  2010-10-20       Impact factor: 4.285

Review 4.  Steroidogenic factor-1 (SF-1, Ad4BP, NR5A1) and disorders of testis development.

Authors:  L Lin; J C Achermann
Journal:  Sex Dev       Date:  2008-11-05       Impact factor: 1.824

Review 5.  Steroidogenic factor-1 and human disease.

Authors:  Ranna El-Khairi; John C Achermann
Journal:  Semin Reprod Med       Date:  2012-10-08       Impact factor: 1.303

6.  Impaired follicle development and infertility in female mice lacking steroidogenic factor 1 in ovarian granulosa cells.

Authors:  Carla Pelusi; Yayoi Ikeda; Mohamad Zubair; Keith L Parker
Journal:  Biol Reprod       Date:  2008-08-13       Impact factor: 4.285

7.  Mutations in NR5A1 associated with ovarian insufficiency.

Authors:  Diana Lourenço; Raja Brauner; Lin Lin; Arantzazu De Perdigo; Georges Weryha; Mihaela Muresan; Radia Boudjenah; Gil Guerra-Junior; Andréa T Maciel-Guerra; John C Achermann; Ken McElreavey; Anu Bashamboo
Journal:  N Engl J Med       Date:  2009-02-25       Impact factor: 91.245

Review 8.  Steroidogenic factor-1 (SF-1, NR5A1) and human disease.

Authors:  Bruno Ferraz-de-Souza; Lin Lin; John C Achermann
Journal:  Mol Cell Endocrinol       Date:  2010-11-13       Impact factor: 4.102

9.  The spectrum of phenotypes associated with mutations in steroidogenic factor 1 (SF-1, NR5A1, Ad4BP) includes severe penoscrotal hypospadias in 46,XY males without adrenal insufficiency.

Authors:  Birgit Köhler; Lin Lin; Inas Mazen; Cigdem Cetindag; Heike Biebermann; Ilker Akkurt; Rainer Rossi; Olaf Hiort; Annette Grüters; John C Achermann
Journal:  Eur J Endocrinol       Date:  2009-05-13       Impact factor: 6.664

10.  A novel NR5A1 variant in an infant with elevated testosterone from an Australasian cohort of 46,XY patients with disorders of sex development.

Authors:  Joyce Y Wu; Ivan N McGown; Lin Lin; John C Achermann; Mark Harris; David M Cowley; Salim Aftimos; Kristen A Neville; Catherine S Choong; Andrew M Cotterill
Journal:  Clin Endocrinol (Oxf)       Date:  2013-04       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.